Word

PLEXPLUS

Status

Registered

Status Code

700

Status Date

Tuesday, May 23, 2023

Serial Number

79337468

Registration Number

7057884

Registration Date

Tuesday, May 23, 2023

Mark Type

4000

Filing Date

Monday, September 27, 2021

Published for Opposition

Tuesday, March 7, 2023

Trademark Owner History

SpeeDx Pty Ltd - Original Registrant

Classifications

5 Pharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing preparations for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostic preparations for medical or veterinary use; biological chemical diagnostic test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

1 Chemicals used in industry and science; chemical preparations for use in photography; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; reagents and reactants in this class for scientific and research use, medical research use, and nonmedical use; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acid for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring

44 Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine; molecular medical diagnostics testing

10 Surgical apparatus and instruments; medical and veterinary apparatus and instruments being diagnostic testing apparatus and instruments for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits consisting primarily of diagnostic testing apparatus and instruments for the purpose of detecting antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; point of care medical devices being diagnostic testing apparatus for the purpose of detecting antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

42 Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; custom design and development of biochemical assays

PLEX PLUS

Trademark Events

Sep 17, 2023

Final Decision Transaction Processed By Ib

Aug 28, 2023

Final Disposition Notice Sent To Ib

Aug 28, 2023

Final Disposition Processed

Aug 23, 2023

Final Disposition Notice Created, To Be Sent To Ib

May 23, 2023

Notice Of Registration Confirmation Emailed

May 23, 2023

Registered-Principal Register

Mar 7, 2023

Official Gazette Publication Confirmation E-Mailed

Mar 7, 2023

Published For Opposition

Mar 6, 2023

Notification Processed By Ib

Feb 15, 2023

Notification Of Possible Opposition Sent To Ib

Feb 15, 2023

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Feb 15, 2023

Notification Of Notice Of Publication E-Mailed

Jan 27, 2023

Approved For Pub - Principal Register

Jan 27, 2023

Examiner's Amendment Entered

Jan 27, 2023

Notification Of Examiners Amendment E-Mailed

Jan 27, 2023

Examiners Amendment E-Mailed

Jan 27, 2023

Examiners Amendment -Written

Jan 19, 2023

Previous Allowance Count Withdrawn

Jan 17, 2023

Withdrawn From Pub - Og Review Query

Dec 30, 2022

Approved For Pub - Principal Register

Dec 29, 2022

Teas/Email Correspondence Entered

Dec 28, 2022

Correspondence Received In Law Office

Dec 28, 2022

Teas Response To Office Action Received

Dec 12, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Dec 12, 2022

Teas Change Of Correspondence Received

Dec 12, 2022

Teas Change Of Domestic Representatives Address

Dec 12, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 12, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 12, 2022

Teas Change Of Owner Address Received

Jul 20, 2022

Refusal Processed By Ib

Jun 29, 2022

Non-Final Action Mailed - Refusal Sent To Ib

Jun 29, 2022

Refusal Processed By Mpu

Jun 29, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Jun 28, 2022

Non-Final Action Written

Jun 28, 2022

Assigned To Examiner

Apr 12, 2022

Application Filing Receipt Mailed

Apr 8, 2022

New Application Office Supplied Data Entered

Apr 7, 2022

Sn Assigned For Sect 66a Appl From Ib